- Home
- PRTA vs CLDT Comparison
PRTA vs CLDT Comparison
Compare PRTA & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- CLDT
- Stock Information
- Founded
- PRTA 2012
- CLDT 2009
- Country
- PRTA Ireland
- CLDT United States
- Employees
- PRTA N/A
- CLDT N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- CLDT Real Estate Investment Trusts
- Sector
- PRTA Health Care
- CLDT Real Estate
- Exchange
- PRTA Nasdaq
- CLDT Nasdaq
- Market Cap
- PRTA 346.4M
- CLDT 351.7M
- IPO Year
- PRTA N/A
- CLDT 2010
- Fundamental
- Price
- PRTA $6.29
- CLDT $7.03
- Analyst Decision
- PRTA Buy
- CLDT Strong Buy
- Analyst Count
- PRTA 9
- CLDT 2
- Target Price
- PRTA $27.67
- CLDT $10.75
- AVG Volume (30 Days)
- PRTA 1.3M
- CLDT 251.1K
- Earning Date
- PRTA 08-07-2025
- CLDT 08-06-2025
- Dividend Yield
- PRTA N/A
- CLDT 5.11%
- EPS Growth
- PRTA N/A
- CLDT N/A
- EPS
- PRTA N/A
- CLDT 0.06
- Revenue
- PRTA $137,935,000.00
- CLDT $316,297,000.00
- Revenue This Year
- PRTA N/A
- CLDT N/A
- Revenue Next Year
- PRTA $122.02
- CLDT $1.12
- P/E Ratio
- PRTA N/A
- CLDT $121.56
- Revenue Growth
- PRTA 54.55
- CLDT 1.79
- 52 Week Low
- PRTA $4.32
- CLDT $5.83
- 52 Week High
- PRTA $25.42
- CLDT $10.00
- Technical
- Relative Strength Index (RSI)
- PRTA 56.80
- CLDT 46.65
- Support Level
- PRTA $6.16
- CLDT $7.08
- Resistance Level
- PRTA $6.60
- CLDT $7.41
- Average True Range (ATR)
- PRTA 0.27
- CLDT 0.17
- MACD
- PRTA 0.04
- CLDT -0.01
- Stochastic Oscillator
- PRTA 67.90
- CLDT 27.45
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.